BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

199 related articles for article (PubMed ID: 30879546)

  • 1. Influence of Pulmonary Hypertension on Intrahospital Mortality in Lung Transplantation for Interstitial Lung Disease.
    Corral-Blanco M; Prudencio-Ribera VC; Jarrín-Estupiñán ME; Alonso-Moralejo R; Pérez-González V; Meneses-Pardo JC; Hermira-Anchuelo A; De Pablo-Gafas A
    Transplant Proc; 2019 Mar; 51(2):380-382. PubMed ID: 30879546
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Clinical characteristics and survival in systemic sclerosis-related pulmonary hypertension associated with interstitial lung disease.
    Launay D; Humbert M; Berezne A; Cottin V; Allanore Y; Couderc LJ; Bletry O; Yaici A; Hatron PY; Mouthon L; Le Pavec J; Clerson P; Hachulla E
    Chest; 2011 Oct; 140(4):1016-1024. PubMed ID: 21474572
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Analysis of Intrahospital Mortality in Patients With Lung Transplant Due to Diffuse Parenchymal Lung Disease.
    Prudencio-Ribera VC; Corral-Blanco M; Jarrín-Estupiñán ME; Alonso-Moralejo R; Pérez-González V; Martínez-Serna I; González-Serrano M; De Pablo-Gafas A
    Transplant Proc; 2019 Mar; 51(2):372-375. PubMed ID: 30879544
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Borderline pulmonary hypertension is associated with exercise intolerance and increased risk for acute exacerbation in patients with interstitial lung disease.
    Nemoto K; Oh-Ishi S; Akiyama T; Yabuuchi Y; Goto H; Nonaka M; Sasatani Y; Tachi H; Arai N; Ishikawa H; Hyodo K; Hase I; Miura Y; Takaku T; Hayashihara K; Saito T
    BMC Pulm Med; 2019 Sep; 19(1):167. PubMed ID: 31477076
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prevalence and characteristics of moderate to severe pulmonary hypertension in systemic sclerosis with and without interstitial lung disease.
    Launay D; Mouthon L; Hachulla E; Pagnoux C; de Groote P; Remy-Jardin M; Matran R; Lambert M; Queyrel V; Morell-Dubois S; Guillevin L; Hatron PY
    J Rheumatol; 2007 May; 34(5):1005-11. PubMed ID: 17444586
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Survival after lung transplantation in systemic sclerosis. A systematic review.
    Khan IY; Singer LG; de Perrot M; Granton JT; Keshavjee S; Chau C; Kron A; Johnson SR
    Respir Med; 2013 Dec; 107(12):2081-7. PubMed ID: 24113572
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Survival in pulmonary hypertension associated with the scleroderma spectrum of diseases: impact of interstitial lung disease.
    Mathai SC; Hummers LK; Champion HC; Wigley FM; Zaiman A; Hassoun PM; Girgis RE
    Arthritis Rheum; 2009 Feb; 60(2):569-77. PubMed ID: 19180517
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Impact of pulmonary hypertension on exercise performance in patients with interstitial lung disease undergoing evaluation for lung transplantation.
    Armstrong HF; Schulze PC; Bacchetta M; Thirapatarapong W; Bartels MN
    Respirology; 2014 Jul; 19(5):675-82. PubMed ID: 24797365
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Single- Versus Double-Lung Transplantation in Pulmonary Fibrosis: Impact of Age and Pulmonary Hypertension.
    Villavicencio MA; Axtell AL; Osho A; Astor T; Roy N; Melnitchouk S; D'Alessandro D; Tolis G; Raz Y; Neuringer I; Sundt TM
    Ann Thorac Surg; 2018 Sep; 106(3):856-863. PubMed ID: 29803692
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Interstitial lung disease increases mortality in systemic sclerosis patients with pulmonary arterial hypertension without affecting hemodynamics and exercise capacity.
    Michelfelder M; Becker M; Riedlinger A; Siegert E; Drömann D; Yu X; Petersen F; Riemekasten G
    Clin Rheumatol; 2017 Feb; 36(2):381-390. PubMed ID: 28028682
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Impact of post-capillary pulmonary hypertension on mortality in interstitial lung disease.
    Teramachi R; Taniguchi H; Kondoh Y; Kimura T; Kataoka K; Yokoyama T; Furukawa T; Yagi M; Sakamoto K; Hashimoto N; Hasegawa Y
    Respir Investig; 2021 May; 59(3):342-349. PubMed ID: 33579646
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Survival in pulmonary hypertension due to chronic lung disease: Influence of low diffusion capacity of the lungs for carbon monoxide.
    Rose L; Prins KW; Archer SL; Pritzker M; Weir EK; Misialek JR; Thenappan T
    J Heart Lung Transplant; 2019 Feb; 38(2):145-155. PubMed ID: 30391191
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prevalence of Pulmonary Hypertension and its Influence on Survival in Patients With Advanced Chronic Obstructive Pulmonary Disease Prior to Lung Transplantation.
    Hayes D; Black SM; Tobias JD; Mansour HM; Whitson BA
    COPD; 2016; 13(1):50-6. PubMed ID: 26366936
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Lung transplant for interstitial lung disease: outcomes before and after implementation of the united network for organ sharing lung allocation scoring system.
    De Oliveira NC; Osaki S; Maloney J; Cornwell RD; Meyer KC
    Eur J Cardiothorac Surg; 2012 Mar; 41(3):680-5. PubMed ID: 22219404
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pulmonary hypertension in interstitial lung disease: prevalence, prognosis and 6 min walk test.
    Andersen CU; Mellemkjær S; Hilberg O; Nielsen-Kudsk JE; Simonsen U; Bendstrup E
    Respir Med; 2012 Jun; 106(6):875-82. PubMed ID: 22425136
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Limitations to the 6-minute walk test in interstitial lung disease and pulmonary hypertension in scleroderma.
    Garin MC; Highland KB; Silver RM; Strange C
    J Rheumatol; 2009 Feb; 36(2):330-6. PubMed ID: 19208563
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Improved transplant-free survival in patients with systemic sclerosis-associated pulmonary hypertension and interstitial lung disease.
    Volkmann ER; Saggar R; Khanna D; Torres B; Flora A; Yoder L; Clements PJ; Elashoff RM; Ross DJ; Agrawal H; Borazan N; Furst DE; Saggar R
    Arthritis Rheumatol; 2014 Jul; 66(7):1900-8. PubMed ID: 24729406
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Patterns of interstitial lung disease and mortality in rheumatoid arthritis.
    Zamora-Legoff JA; Krause ML; Crowson CS; Ryu JH; Matteson EL
    Rheumatology (Oxford); 2017 Mar; 56(3):344-350. PubMed ID: 27940586
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pulmonary hypertension in chronic lung diseases.
    Seeger W; Adir Y; Barberà JA; Champion H; Coghlan JG; Cottin V; De Marco T; Galiè N; Ghio S; Gibbs S; Martinez FJ; Semigran MJ; Simonneau G; Wells AU; Vachiéry JL
    J Am Coll Cardiol; 2013 Dec; 62(25 Suppl):D109-16. PubMed ID: 24355635
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pulmonary arterial wall disease in COPD and interstitial lung diseases candidates for lung transplantation.
    Domingo E; Grignola JC; Aguilar R; Messeguer ML; Roman A
    Respir Res; 2017 May; 18(1):85. PubMed ID: 28477618
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.